Financials Organigram Holdings Inc.

Equities

OGI

CA68620P7056

Healthcare Facilities & Services

Market Closed - Toronto S.E. 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.57 CAD +0.39% Intraday chart for Organigram Holdings Inc. -1.53% +49.42%

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 710.6 274.3 875.5 382.7 144.9 265.7 - -
Enterprise Value (EV) 1 712.3 314.8 692.2 284.4 144.9 265.7 265.7 265.7
P/E ratio -66.9 x -1.79 x -5.73 x -26.5 x -0.59 x -24.5 x -21.4 x 25.7 x
Yield - - - - - - - -
Capitalization / Revenue 8.84 x 3.16 x 11.1 x 2.62 x 0.9 x 1.62 x 1.37 x 1.02 x
EV / Revenue 8.84 x 3.16 x 11.1 x 2.62 x 0.9 x 1.62 x 1.37 x 1.02 x
EV / EBITDA 35.7 x -11.6 x -29.2 x 110 x 24.4 x 37.1 x 16.7 x 7.11 x
EV / FCF -4.94 x -2.24 x -21.7 x -4.5 x -2.13 x 29 x -16.6 x -
FCF Yield -20.2% -44.6% -4.61% -22.2% -46.9% 3.45% -6.02% -
Price to Book 1.96 x 0.92 x - - - - - -
Nbr of stocks (in thousands) 39,045 48,627 74,954 78,427 80,520 103,370 - -
Reference price 2 18.20 5.640 11.68 4.880 1.800 2.570 2.570 2.570
Announcement Date 11/25/19 11/30/20 11/23/21 11/29/22 12/19/23 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 80.41 86.8 79.16 145.8 161.6 164.1 193.7 260.8
EBITDA 1 19.9 -23.63 -30.03 3.484 5.951 7.161 15.87 37.35
EBIT 1 5.487 -67.46 -76.99 -34.11 -275.8 -34.54 -18.54 13.7
Operating Margin 6.82% -77.72% -97.26% -23.39% -170.6% -21.05% -9.57% 5.25%
Earnings before Tax (EBT) 1 -5.875 -146.6 -130.7 -14.37 -252.4 3.064 -20.22 13.7
Net income 1 -9.542 -136.2 -130.7 -14.28 -248.6 -13.82 -16.06 10
Net margin -11.87% -156.87% -165.11% -9.8% -153.8% -8.42% -8.29% 3.84%
EPS 2 -0.2720 -3.156 -2.040 -0.1840 -3.058 -0.1050 -0.1200 0.1000
Free Cash Flow 1 -143.8 -122.3 -40.38 -84.96 -67.92 9.158 -16 -
FCF margin -178.88% -140.96% -51.01% -58.27% -42.02% 5.58% -8.26% -
FCF Conversion (EBITDA) - - - - - 127.88% - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 11/25/19 11/30/20 11/23/21 11/29/22 12/19/23 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 24.86 30.38 31.84 38.12 45.48 46.04 36.46 38.26 41.39 45.42 47.25 46.95
EBITDA 1 -4.818 -1.887 1.556 0.583 3.232 -2.36 0.135 0.7487 1.865 3.897 2.65 2.45
EBIT 1 -30.75 -11.88 -9.138 -10.9 -2.187 - -15.93 -7.262 -5.595 -3.534 - -
Operating Margin -123.67% -39.1% -28.7% -28.61% -4.81% - -43.69% -18.98% -13.52% -7.78% - -
Earnings before Tax (EBT) 1 -25.97 -1.305 -4.144 -2.479 -6.443 -35.27 -15.75 -7.61 -6.098 -3.973 - -
Net income 1 -25.97 -1.305 -4.047 -2.787 -6.144 -32.99 -15.75 -7.61 -6.098 -3.973 - -
Net margin -104.45% -4.3% -12.71% -7.31% -13.51% -71.66% -43.2% -19.89% -14.73% -8.75% - -
EPS 2 -0.1640 -0.0160 -0.0520 -0.0360 -0.0800 -0.1050 -0.1940 -0.0800 -0.0633 -0.0400 - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 11/23/21 1/11/22 4/12/22 7/14/22 11/29/22 12/19/23 2/13/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1.64 40.5 - - - - - -
Net Cash position - - 183 98.4 - - - -
Leverage (Debt/EBITDA) 0.0825 x -1.715 x - - - - - -
Free Cash Flow 1 -144 -122 -40.4 -85 -67.9 9.16 -16 -
ROE (net income / shareholders' equity) -3.73% - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 9.280 6.160 - - - - - -
Cash Flow per Share 0.5800 -1.720 - - - - - -
Capex 1 109 77.2 11.8 48.7 29.1 6.84 8.5 -
Capex / Sales 135.26% 88.97% 14.89% 33.43% 18.03% 4.17% 4.39% -
Announcement Date 11/25/19 11/30/20 11/23/21 11/29/22 12/19/23 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.57 CAD
Average target price
3.7 CAD
Spread / Average Target
+43.97%
Consensus
  1. Stock Market
  2. Equities
  3. OGI Stock
  4. Financials Organigram Holdings Inc.